ReviewFrontiers in immunology2023
Targeting HER3 to overcome EGFR TKI resistance in NSCLC.
Qiuqiang Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this papertrialcites it
ReviewFrontiers in immunology2023
Qiuqiang Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.